Jazz Pharmaceuticals PLC (JAZZ)
107.45
-0.87
(-0.80%)
USD |
NASDAQ |
Apr 25, 16:00
107.45
0.00 (0.00%)
After-Hours: 20:00
Jazz Pharmaceuticals Free Cash Flow: 1.049B for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.049B |
| September 30, 2023 | 867.40M |
| June 30, 2023 | 987.40M |
| March 31, 2023 | 917.98M |
| December 31, 2022 | 773.78M |
| September 30, 2022 | 983.98M |
| June 30, 2022 | 808.93M |
| March 31, 2022 | 621.83M |
| December 31, 2021 | 732.98M |
| September 30, 2021 | 711.34M |
| June 30, 2021 | 708.02M |
| March 31, 2021 | 750.33M |
| December 31, 2020 | 520.39M |
| September 30, 2020 | 454.90M |
| June 30, 2020 | 478.30M |
| March 31, 2020 | 508.65M |
| December 31, 2019 | 594.07M |
| September 30, 2019 | 726.35M |
| June 30, 2019 | 675.97M |
| March 31, 2019 | 645.53M |
| December 31, 2018 | 667.43M |
| September 30, 2018 | 642.17M |
| June 30, 2018 | 530.18M |
| March 31, 2018 | 578.38M |
| December 31, 2017 | 579.14M |
| Date | Value |
|---|---|
| September 30, 2017 | 570.87M |
| June 30, 2017 | 580.97M |
| March 31, 2017 | 429.49M |
| December 31, 2016 | 408.95M |
| September 30, 2016 | 345.91M |
| June 30, 2016 | 400.18M |
| March 31, 2016 | 554.27M |
| December 31, 2015 | 495.98M |
| September 30, 2015 | 499.70M |
| June 30, 2015 | 376.34M |
| March 31, 2015 | 310.58M |
| December 31, 2014 | 168.63M |
| September 30, 2014 | 124.48M |
| June 30, 2014 | 205.56M |
| March 31, 2014 | 148.92M |
| December 31, 2013 | 272.17M |
| September 30, 2013 | 293.85M |
| June 30, 2013 | 206.60M |
| March 31, 2013 | 267.96M |
| December 31, 2012 | 227.28M |
| September 30, 2012 | 171.44M |
| June 30, 2012 | 175.61M |
| March 31, 2012 | 145.32M |
| December 31, 2011 | 145.82M |
| September 30, 2011 | 125.72M |
Free Cash Flow Range, Past 5 Years
454.90M
Minimum
Sep 2020
1.049B
Maximum
Dec 2023
730.09M
Average
726.35M
Median
Sep 2019
Free Cash Flow Benchmarks
| Alkermes PLC | 353.30M |
| Endo International PLC | 340.77M |
| Medtronic PLC | 4.931B |
| Perrigo Co PLC | 303.80M |
| Iterum Therapeutics PLC | -39.34M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 167.34M |
| Cash from Investing (Quarterly) | 101.80M |
| Cash from Financing (Quarterly) | -100.31M |
| Free Cash Flow Per Share (Quarterly) | 1.999 |
| Free Cash Flow to Equity (Quarterly) | 141.56M |
| Free Cash Flow to Firm (Quarterly) | 247.38M |
| Free Cash Flow Yield | 13.55% |